PURPOSE: Despite the clear demonstration that different histological subtypes of renal cell carcinoma show distinct pathogenesis and genetic alterations, the impact of histology on prognosis remains controversial. We evaluated our experience with tumor histology in patients with localized renal cell carcinoma. MATERIALS AND METHODS: We identified 1,863 patients with localized clear cell, papillary or chromophobe renal cell carcinoma who were treated surgically between 1989 and 2006 at our tertiary care center. Cox proportional hazards regression models were used to evaluate the relationship between tumor histology and outcome, defined as metastasis or death from disease, adjusting for age, sex, operation type, American Society of Anesthesiologists score, TNM stage and tumor size. RESULTS: Of 1,863 patients 1,333 (72%) had clear cell histology, and 310 (17%) and 220 (12%) had papillary and chromophobe renal cell carcinoma, respectively. Median followup in patients without an event was 3.4 years. On univariate analysis patients with clear cell histology had a worse clinical outcome. Five-year probability of freedom from metastasis or death from disease was 86% (95% CI 84, 88), 95% (95% CI 91, 97) and 92% (95% CI 85, 96) in patients with clear cell, papillary and chromophobe histology, respectively (p <0.001). On multivariate analysis chromophobe (HR 0.40; 95% CI 0.20, 0.80) and papillary (HR 0.62; 95% CI 0.34, 1.14) histology was also significantly associated with better outcome (p = 0.014). CONCLUSIONS: Clear cell histology seems to be independently associated with worse outcomes in patients who undergo surgery for renal cell carcinoma even after controlling for widely accepted factors influencing prognosis.
PURPOSE: Despite the clear demonstration that different histological subtypes of renal cell carcinoma show distinct pathogenesis and genetic alterations, the impact of histology on prognosis remains controversial. We evaluated our experience with tumor histology in patients with localized renal cell carcinoma. MATERIALS AND METHODS: We identified 1,863 patients with localized clear cell, papillary or chromophobe renal cell carcinoma who were treated surgically between 1989 and 2006 at our tertiary care center. Cox proportional hazards regression models were used to evaluate the relationship between tumor histology and outcome, defined as metastasis or death from disease, adjusting for age, sex, operation type, American Society of Anesthesiologists score, TNM stage and tumor size. RESULTS: Of 1,863 patients 1,333 (72%) had clear cell histology, and 310 (17%) and 220 (12%) had papillary and chromophobe renal cell carcinoma, respectively. Median followup in patients without an event was 3.4 years. On univariate analysis patients with clear cell histology had a worse clinical outcome. Five-year probability of freedom from metastasis or death from disease was 86% (95% CI 84, 88), 95% (95% CI 91, 97) and 92% (95% CI 85, 96) in patients with clear cell, papillary and chromophobe histology, respectively (p <0.001). On multivariate analysis chromophobe (HR 0.40; 95% CI 0.20, 0.80) and papillary (HR 0.62; 95% CI 0.34, 1.14) histology was also significantly associated with better outcome (p = 0.014). CONCLUSIONS: Clear cell histology seems to be independently associated with worse outcomes in patients who undergo surgery for renal cell carcinoma even after controlling for widely accepted factors influencing prognosis.
Authors: Jean-Jacques Patard; Emmanuelle Leray; Nathalie Rioux-Leclercq; Luca Cindolo; Vincenzo Ficarra; Amnon Zisman; Alexandre De La Taille; Jacques Tostain; Walter Artibani; Claude C Abbou; Bernard Lobel; François Guillé; Dominique K Chopin; Peter F A Mulders; Christopher G Wood; David A Swanson; Robert A Figlin; Arie S Belldegrun; Allan J Pantuck Journal: J Clin Oncol Date: 2005-04-20 Impact factor: 44.544
Authors: John S Lam; Oleg Shvarts; Jonathan W Said; Allan J Pantuck; David B Seligson; Michael E Aldridge; Matthew H T Bui; Xueli Liu; Steve Horvath; Robert A Figlin; Arie S Belldegrun Journal: Cancer Date: 2005-06-15 Impact factor: 6.860
Authors: Shomik Sengupta; Christine M Lohse; Bradley C Leibovich; Igor Frank; R Houston Thompson; W Scott Webster; Horst Zincke; Michael L Blute; John C Cheville; Eugene D Kwon Journal: Cancer Date: 2005-08-01 Impact factor: 6.860
Authors: Audrey N Schuetz; Qiqin Yin-Goen; Mahul B Amin; Carlos S Moreno; Cynthia Cohen; Christopher D Hornsby; Wen Li Yang; John A Petros; Muta M Issa; John G Pattaras; Kenneth Ogan; Fray F Marshall; Andrew N Young Journal: J Mol Diagn Date: 2005-05 Impact factor: 5.568
Authors: G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar Journal: J Pathol Date: 1997-10 Impact factor: 7.996
Authors: Jean-Jacques Patard; Hyung L Kim; John S Lam; Frederick J Dorey; Allan J Pantuck; Amnon Zisman; Vincenzo Ficarra; Ken-Ryu Han; Luca Cindolo; Alexandre De La Taille; Jacques Tostain; Walter Artibani; Colin P Dinney; Christopher G Wood; David A Swanson; Claude C Abbou; Bernard Lobel; Peter F A Mulders; Dominique K Chopin; Robert A Figlin; Arie S Belldegrun Journal: J Clin Oncol Date: 2004-08-15 Impact factor: 44.544
Authors: Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo Journal: Ann Surg Oncol Date: 2004-01 Impact factor: 5.344
Authors: Adam C Reese; Pamela T Johnson; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf; Elliot K Fishman; George J Netto; Christian P Pavlovich Journal: Urol Oncol Date: 2014-07-09 Impact factor: 3.498
Authors: Byron H Lee; Andrew Feifer; Michael A Feuerstein; Nicole E Benfante; Lei Kou; Changhong Yu; Michael W Kattan; Paul Russo Journal: Eur Urol Focus Date: 2016-07-28
Authors: Andrew B Rosenkrantz; Aarti Sekhar; Elizabeth M Genega; Jonathan Melamed; James S Babb; Amish D Patel; Andy Lo; Robert M Najarian; Muneeb Ahmed; Ivan Pedrosa Journal: Eur Radiol Date: 2012-08-21 Impact factor: 5.315
Authors: Robert J Hamilton; Daniel Morilla; Fernando Cabrera; Michael Leapman; Ling Y Chen; Melanie Bernstein; A Ari Hakimi; Victor E Reuter; Paul Russo Journal: J Urol Date: 2013-11-26 Impact factor: 7.450
Authors: Hebert Alberto Vargas; Holly G Delaney; Eithne M Delappe; Ya Wang; Junting Zheng; Chaya S Moskowitz; Yongqiang Tan; Binsheng Zhao; Lawrence H Schwartz; Hedvig Hricak; Paul Russo; Oguz Akin Journal: J Magn Reson Imaging Date: 2012-11-13 Impact factor: 4.813
Authors: Daniel P Nguyen; Antoni Vilaseca; Emily A Vertosick; Renato B Corradi; Karim A Touijer; Nicole E Benfante; Daniel D Sjoberg; Paul Russo Journal: World J Urol Date: 2015-07-28 Impact factor: 4.226